Clinical Trials
4 trialsNCT00648037 2016-02-01
Rituximab (Rituxan) for the Prevention of EBV-LPD Epstein Barr Virus (EBV) Lymphoproliferative Disorder Post T Cell Depleted Unrelated and HLA Mis-matched Related HSCT
Memorial Sloan Kettering Cancer Center
Phase NA Completed
NCT01230788 2014-12-01
Rituximab
Emory University
Phase NA Terminated
NCT00476229 2012-08-07
Thymoglobulin and Total Lymphoid Irradiation for Hematologic Malignancies
M.D. Anderson Cancer Center
Phase NA Completed
NCT00038844 2011-11-02
Safety and Efficacy of Campath in Nonmyeloablative Transplantation
M.D. Anderson Cancer Center
Phase NA Completed